| The Regents of the University of California | 556 | 61% |
| BASF SE | 344 | 40% |
| The Procter & Gamble Company | 295 | 27% |
| L'Oréal | 295 | 76% |
| Board of Regents of the University of Texas System | 247 | 64% |
| Massachusetts Institute of Technology | 199 | 60% |
| The Board of Trustees of the Leland Stanford Junior University | 191 | 62% |
| The Johns Hopkins University | 182 | 62% |
| Nestlé S.A. | 176 | 25% |
| The Regents of the University of Michigan | 143 | 39% |
| Regeneron Pharmaceuticals Inc. | 142 | 84% |
| Amgen Inc. | 137 | 58% |
| Sanofi S.A. | 132 | 28% |
| Henkel AG & Co. KGaA | 131 | 28% |
| THE GENERAL HOSPITAL Corporation | 128 | 62% |
| Purdue Research Foundation | 127 | 41% |
| President and Fellows of Harvard College | 124 | 70% |
| Illumina Inc. | 122 | 69% |
| The Trustees of the University of Pennsylvania | 119 | 74% |
| Seoul National University R&DB Foundation | 117 | 31% |
| Arizona Board of Regents on Behalf of Arizona State University | 109 | 35% |
| Mayo Foundation for Medical Education and Research | 108 | 41% |
| Syngenta AG | 108 | 95% |
| Northwestern University | 106 | 55% |
| Genentech Inc. | 98 | 80% |
| Wisconsin Alumni Research Foundation | 96 | 59% |
| University of Florida Research Foundation Inc. | 96 | 77% |
| University of Pittsburgh | 95 | 66% |
| Hoffmann-La Roche Inc. | 95 | 79% |
| California Institute of Technology | 92 | 45% |
| The Trustees of Columbia University in the City of New York | 92 | 54% |
| Conopco, Inc. d/b/a Unilever | 91 | 53% |
| The Ohio State University | 90 | 60% |
| 10x Genomics Inc. | 89 | 75% |
| Merck Patent GmbH | 89 | 40% |
| Columbia University | 88 | 62% |
| Evonik Operations GmbH | 86 | 52% |
| GEORGIA TECH RESEARCH Corporation | 85 | 28% |
| Duke University | 85 | 72% |
| Korea Advanced Institute of Science and Technology | 84 | 21% |
| Arizona Board of Regents on Behalf of the University of Arizona | 83 | 56% |
| Kao Corporation | 80 | 76% |
| Johnson & Johnson | 79 | 24% |
| University of Washington | 79 | 59% |
| DSM IP Assets B.V. | 78 | 58% |
| Thermo Fisher Scientific | 77 | 68% |
| Washington University | 77 | 65% |
| Korea University Research and Business Foundation | 76 | 35% |
| Regents of the University of Minnesota | 76 | 44% |
| Novartis AG | 76 | 97% |
| Colgate-Palmolive Company | 74 | 80% |
| CJ CheilJedang Corporation | 73 | 51% |
| Bayer Aktiengesellschaft | 69 | 77% |
| Yale University | 69 | 76% |
| Denka Company Limited | 69 | 25% |
| The Regents of the University of Colorado | 68 | 43% |
| University of Massachusetts | 67 | 67% |
| Daicel Corporation | 67 | 27% |
| The University of Tokyo | 67 | 40% |
| Novozymes A/S | 65 | 69% |
| Merck Sharp & Dohme LLC | 64 | 84% |
| Sekisui Chemical Co., Ltd. | 64 | 25% |
| SUMITOMO CHEMICAL Company, Limited | 64 | 33% |
| Roche Diagnostics Operations Inc. | 62 | 41% |
| University of Virginia Patent Foundation | 61 | 62% |
| Kaneka Corporation | 59 | 33% |
| Mitsubishi Gas Chemical Company, Inc. | 59 | 22% |
| Pioneer Hi-bred International Inc. | 58 | 98% |
| Vanderbilt University | 58 | 36% |
| Nanyang Technological University | 58 | 37% |
| Zhejiang University | 57 | 37% |
| Monsanto Technology LLC | 56 | 84% |
| The Texas A&M University System | 56 | 50% |
| The Board of Trustees of the University of Illinois | 56 | 44% |
| Centre National de la Recherche Scientifique | 56 | 37% |
| Pfizer Inc. | 56 | 89% |
| Eli Lilly and Company | 55 | 76% |
| University of South Florida | 55 | 46% |
| Boehringer Ingelheim International GmbH | 55 | 83% |
| Uif (university Industry Foundation), Yonsei University | 54 | 17% |
| Givaudan S.A. | 54 | 54% |
| University of Southern California | 53 | 55% |
| Janssen Biotech Inc. | 52 | 83% |
| Bristol-Myers Squibb Company | 52 | 84% |
| Ramot At Tel-aviv University Ltd. | 52 | 74% |
| Korea Institute of Science and Technology | 51 | 31% |
| Firmenich S.A. | 51 | 44% |
| Tohoku University | 50 | 54% |
| Iucf-hyu (industry-university Cooperation Foundation Hanyang University) | 50 | 22% |
| The Research Foundation for the State University of New York | 50 | 36% |
| Nissan Chemical Corporation | 49 | 32% |
| Osaka University | 49 | 41% |
| Takeda Pharmaceutical Company Limited | 49 | 95% |
| Rutgers, The State University of New Jersey | 48 | 66% |
| Dana-Farber Cancer Institute Inc. | 47 | 100% |
| The University of North Carolina at Chapel Hill | 47 | 75% |
| Flagship Pioneering Inc. | 47 | 98% |
| University of Utah Research Foundation | 47 | 58% |
| United States Department of Health and Human Services | 47 | 100% |
| Virginia Polytechnic Institute and State University | 46 | 29% |
| Case Western Reserve University | 46 | 53% |
| National University of Singapore | 46 | 45% |
| SHISEIDO Company, Ltd. | 46 | 91% |
| VERADERMICS INCORPORATED | 45 | 95% |
| Chugai Seiyaku Kabushiki Kaisha | 45 | 95% |
| The Brigham and Women's Hospital Inc. | 45 | 62% |
| Otsuka Pharmaceutical Co., Ltd. | 44 | 75% |
| North Carolina State University | 44 | 56% |
| The University of Chicago | 44 | 73% |
| Astrazeneca AB | 44 | 88% |
| H. Lee Moffitt Cancer Center and Research Institute Inc. | 44 | 92% |
| City of Hope | 43 | 94% |
| Symrise AG | 43 | 63% |
| New York University | 42 | 53% |
| King Abdullah University of Science and Technology | 42 | 28% |
| The University of Hong Kong | 42 | 63% |
| Agency for Science, Technology and Research | 42 | 51% |
| Covestro AG | 41 | 26% |
| University of South Carolina | 41 | 42% |
| Oxford University Innovation Limited | 41 | 62% |
| National Institute of Advanced Industrial Science and Technology | 40 | 23% |
| University of Cincinnati | 40 | 36% |
| The Trustees of Princeton University | 40 | 56% |
| City University of Hong Kong | 40 | 23% |
| Alnylam Pharmaceuticals Inc. | 40 | 100% |
| Yeda Research and Development Co. Ltd. | 40 | 83% |
| Emory University | 39 | 73% |
| Agilent Technologies Inc. | 39 | 33% |
| Ajinomoto Co., Inc. | 38 | 52% |
| Northeastern University | 37 | 21% |
| Imperial College Innovations Limited | 37 | 62% |
| Memorial Sloan Kettering Cancer Center | 37 | 91% |
| Eidgenössische Technische Hochschule Zürich | 36 | 26% |
| Ajou University Industry-Academic Cooperation Foundation | 36 | 41% |
| Cambridge Enterprise Limited | 36 | 61% |
| Iowa State University Research Foundation Inc. | 35 | 30% |
| Technion Research & Development Foundation Limited | 35 | 52% |
| The Penn State Research Foundation | 35 | 36% |
| The Trustees of Dartmouth College | 35 | 61% |
| University of Maryland, College Park | 35 | 29% |
| Rohm And Haas Company | 35 | 29% |
| Baylor College of Medicine | 35 | 87% |
| Industry-academic Cooperation Foundation, Yonsei University | 34 | 43% |
| Baxter Healthcare S.A. | 34 | 27% |
| Janssen Pharmaceutica N.V. | 34 | 82% |
| Tempus AI Inc. | 33 | 43% |
| The United States Government as represented by the Department of Veterans Affairs | 33 | 77% |
| GENZYME Corporation | 33 | 93% |
| Amano Enzyme Inc. | 33 | 29% |
| Ucl Business Ltd. | 33 | 74% |
| Gilead Sciences Inc. | 32 | 100% |
| Icahn School of Medicine At Mount Sinai | 32 | 81% |
| Max-planck-gesellschaft Zur Förderung der Wissenschaften E.v. | 32 | 41% |
| Rohm and Haas Electronic Materials Korea Ltd. | 32 | 20% |
| The Hong Kong University of Science and Technology | 31 | 30% |
| Cedars-Sinai Medical Center | 31 | 76% |
| Intervet Inc. | 31 | 92% |
| The Trustees of Indiana University | 31 | 67% |
| AbbVie Inc. | 30 | 82% |
| Riken | 30 | 52% |
| The Curators of the University of Missouri | 30 | 56% |
| University of Kentucky Research Foundation | 30 | 37% |
| Kyoto University | 30 | 59% |
| Grail LLC | 30 | 100% |
| The University of British Columbia | 29 | 54% |
| Katholieke Universiteit Leuven | 29 | 28% |
| National University Corporation Tokai National Higher Education and Research System | 29 | 30% |
| IFP Energies nouvelles | 29 | 27% |
| Nippon Shokubai Co., Ltd. | 28 | 21% |
| Inari Agriculture Technology Inc. | 28 | 100% |
| The Chinese University of Hong Kong | 28 | 65% |
| Brown University | 28 | 48% |
| Tosoh Corporation | 28 | 45% |
| National Research Council of Canada | 28 | 23% |
| Children's Medical Center Corporation | 28 | 72% |
| Roche Sequencing Solutions Inc. | 27 | 83% |
| Mcmaster University | 27 | 48% |
| JSR Corporation | 27 | 27% |
| Glaxosmithkline Biologicals S.A. | 27 | 95% |
| The Children's Hospital of Philadelphia | 27 | 92% |
| ModernaTX Inc. | 26 | 100% |
| University of Rochester | 26 | 42% |
| The Cleveland Clinic Foundation | 26 | 50% |
| William Marsh Rice University | 26 | 43% |
| University of Louisville Research Foundation Inc. | 26 | 64% |
| Chr. Hansen A/S | 26 | 68% |
| Universiteit Gent | 26 | 57% |
| Singular Genomics Systems Inc. | 25 | 95% |
| SYSMEX Corporation | 25 | 33% |
| Guardant Health Inc. | 25 | 85% |
| University Health Network | 25 | 59% |
| AMOREPACIFIC Corporation | 25 | 62% |
| Gwangju Institute of Science and Technology | 25 | 36% |
| Trustees of Tufts College | 25 | 77% |
| École Polytechnique Fédérale de Lausanne | 25 | 35% |
| The University of Toledo | 25 | 60% |
| Danisco US Inc. | 25 | 91% |
| The Children's Medical Center Corporation | 25 | 82% |
| L’Oréal | 6 | 67% |
| Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | 3 | 50% |
| Mayo Foundation for Medical Education and Research | 2 | 100% |
| Korea Advanced Institute Of Science & Technology | 1 | 100% |
| President and Fellows of Harvard College | 1 | 100% |
| Research And Business Foundation Sungkyunkwan University | 1 | 100% |
Prosecution Insights